| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 10/13/2004 | CN1535968A Tetrahydro pyridyl or pyridyl heterocycle derivative |
| 10/13/2004 | CN1535957A New isoquinoline compounds, their preparation method and medicine composition contaning them |
| 10/13/2004 | CN1535722A Colostrum peptide and its application |
| 10/13/2004 | CN1535721A Preparation method of betulin extract, application and its composition |
| 10/13/2004 | CN1535710A Yuanbaofeng nervonic acid soft capsule and its preparation process |
| 10/13/2004 | CN1535706A Medicinal components composition with function of dispelling the effects of alcohol |
| 10/13/2004 | CN1535691A Helicid powder injection preparation and its preparation method |
| 10/13/2004 | CN1535690A Helicid soft capsule and its preparation method |
| 10/13/2004 | CN1535678A Stable acetylglutamine freeze-dried powder injection preparation and preparation process |
| 10/13/2004 | CN1170826C Amide compounds |
| 10/13/2004 | CN1170819C Piperidine alcohols |
| 10/13/2004 | CN1170814C Amide compounds for potentiation of cholinergic activity |
| 10/13/2004 | CN1170811C Branched chain amino acid-dependent aminotransferase inhibitors and their use in treatment of diabetic retinopathy |
| 10/13/2004 | CN1170585C Remedies for nervous diseases |
| 10/13/2004 | CN1170583C Weilingxian wine |
| 10/13/2004 | CN1170574C Areca for giving up smoking and its preparing process |
| 10/13/2004 | CN1170548C Pain relieving ointment and its preparation |
| 10/13/2004 | CN1170544C Use of xenon for treating neurointoxications |
| 10/13/2004 | CN1170542C Oxacarbazepine filme-coated tablets |
| 10/13/2004 | CN1170537C Substituted 1-(piperidin-4-yl)3-(aryl)-isothioureas, ther prepn. and therapeutic use |
| 10/13/2004 | CN1170535C Use of medicine for treatment of migraikne by the administration of alpha-lipoic acid |
| 10/13/2004 | CN1170524C Fentanyl composition for treatment of acute pain |
| 10/12/2004 | US6803484 Sulfonamide derivatives |
| 10/12/2004 | US6803481 Treating different types and symptoms of acute and chronic pain, especially non neuropathic inflammatory pain in mammals. the pain to be treated may be e.g. chronic inflammatory pain, rheumatoid arthritis pain and/or secondary |
| 10/12/2004 | US6803384 Diaminopropionic acid derivatives |
| 10/12/2004 | US6803372 Such as cis-n-(4-benzoylphenyl)-4-hydroxy-3'-oxospiro (cyclohexane-1,1' (3'h)-isobenzofuran)-4-carboxamide for use as neuropeptide y receptor antagonist for treatment bulimia, obesity or diabetes |
| 10/12/2004 | US6803371 For treating cellular proliferative and neurodegenerative diseases |
| 10/12/2004 | US6803368 Antipsychotic aminomethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-1,3-diaza-cyclopenta[a]naphthalene |
| 10/12/2004 | US6803366 Agent for improving learning or memory |
| 10/12/2004 | US6803365 Imidazo[1,3,5]triazinones and the use thereof |
| 10/12/2004 | US6803362 Heterocyclic compounds |
| 10/12/2004 | US6803211 Cancer therapy |
| 10/12/2004 | US6803031 Aerosol comprises particles comprising at least 10 percent by weight of an erectile dysfunction drug, such as sildenafil, tadalafil or vardenafil. |
| 10/07/2004 | WO2004085439A1 Substituted 4-amino[1,2,4]triazolo[4,3-a]quinoxalines |
| 10/07/2004 | WO2004085422A1 Water-soluble thalidomine derivatives |
| 10/07/2004 | WO2004085408A1 2, 3, 6-trisubstituted-4-pyrimidone derivatives |
| 10/07/2004 | WO2004085403A1 Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists |
| 10/07/2004 | WO2004085395A1 Melatonin derivatives and their use for treating neurological dysfunctions |
| 10/07/2004 | WO2004084945A1 Eating controllers |
| 10/07/2004 | WO2004084932A2 Use of clusterin for the treatment and/or prevention of peripheral neurological diseases |
| 10/07/2004 | WO2004084923A1 Antistress agent |
| 10/07/2004 | WO2004084912A1 Remedy for nerve damage |
| 10/07/2004 | WO2004084884A1 Use of tanshinone derivates as cholinesterase inhibitors in treating related diseases |
| 10/07/2004 | WO2004084835A2 Treating immunological disorder using agonists of interleukin-21/ interleukin-21 receptor |
| 10/07/2004 | WO2004084809A2 Neuroprotective macrocylic compounds and methods for their use |
| 10/07/2004 | WO2004075823A3 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 10/07/2004 | WO2004069999A3 Screening method |
| 10/07/2004 | WO2004067568A3 Human il-1 beta antagonists |
| 10/07/2004 | WO2004062561A3 Pharmaceutical compositions comprising fentanyl for intranasal delivery |
| 10/07/2004 | WO2004045518A3 Open chain prolyl urea-related modulators of androgen receptor function |
| 10/07/2004 | WO2004020623B1 Method for producing biodegradable, functionalised polymer particles, and use of the same as medicament carriers |
| 10/07/2004 | WO2004002418A3 Compositions and methods comprising protein activated receptor antagonists |
| 10/07/2004 | WO2004002402A3 Administration of acetylcholinesterase inhibitors to the cerebral spinal fluid |
| 10/07/2004 | WO2003099195A3 Immunomodulatory compounds and methods of use thereof |
| 10/07/2004 | WO2003090697A3 Chimeric hybrid analgesics |
| 10/07/2004 | WO2003078430A8 Amides of acetic and propionic acids |
| 10/07/2004 | WO2003072106A8 Use of tyrosine kinase inhibitors for treating substance use disorders |
| 10/07/2004 | WO2003057725A3 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 10/07/2004 | WO2003053973A8 Pyrazolyl-substituted triazoloquinoxalines |
| 10/07/2004 | WO2002088317A3 Fusion molecules and methods for treatment of immune diseases |
| 10/07/2004 | US20040198980 Selective rxr ligands |
| 10/07/2004 | US20040198979 antagonists of urotensin II; (R) N-[4-Chloro-3-(1-methyl-3-pyrrolidinyloxy)-phenyl]-[3-(2-chlorophenoxy)]benzenesulfonamide for example; treating various disease including cardiovascular disorders, gastrointestinal disorders, and psychological disorders |
| 10/07/2004 | US20040198978 for treating autoimmune diseases selected from psoriasis, multiple sclerosis and rheumatoid arthritis; N-(3-oxoundecanoyl)-L-homoserine lactone (OuDHL) and 2-n-heptyl-3-hydroxy-4(1H)-quinolone for example |
| 10/07/2004 | US20040198832 Compositions and methods for treating amyloidosis |
| 10/07/2004 | US20040198824 enzyme inhibitor; anticancer agents; analgesics; vision defects |
| 10/07/2004 | US20040198820 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity |
| 10/07/2004 | US20040198818 Pharmaceutically acceptable salts of sertraline and pharmaceutical compositions thereof |
| 10/07/2004 | US20040198811 Use of enantiomeric pure escitalopram |
| 10/07/2004 | US20040198810 Use of enantiomeric pure escitalopram |
| 10/07/2004 | US20040198809 Use of enantiomeric pure escitalopram |
| 10/07/2004 | US20040198796 Compounds and methods for treating urinary incontinence |
| 10/07/2004 | US20040198792 Imidazole derivatives modulating the sodium channels |
| 10/07/2004 | US20040198791 Fused imidazole derivative |
| 10/07/2004 | US20040198784 Antitumor agents for treating a tumor of the colon or rectum in a mammal; N-[2,4-dichlorobenzoyl]-5-bromothiophene-2-sulfonamide sodium salt |
| 10/07/2004 | US20040198781 Carbonic anhydrase inhibitor |
| 10/07/2004 | US20040198778 Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof |
| 10/07/2004 | US20040198766 Chemical compounds |
| 10/07/2004 | US20040198753 administering adenosine receptor antagonist ; side effect reduction; parkinson's disease |
| 10/07/2004 | US20040198737 Azaindoles |
| 10/07/2004 | US20040198735 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 10/07/2004 | US20040198733 Obesity; antidiabetic agents; cardiovascular disorders; antilipemic agentsl circadian rhythm disorders; hypotensive agents; antidepressants; anxiolytic agents |
| 10/07/2004 | US20040198732 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals |
| 10/07/2004 | US20040198731 Antidiabetic agents; cardiovascular disorders; anticholesterol agents; antidepressants; schizophrenia; antilipemic agents; circidian rhythm disorders |
| 10/07/2004 | US20040198730 Pyridylfurans and pyrroles as raf kinase inhibitors |
| 10/07/2004 | US20040198726 Tri-and tetraaza-acenaphthylen derivatives as crf receptor antagonists |
| 10/07/2004 | US20040198721 Novel crystal forms, methods for their preparation and method for preparation of olanzapine |
| 10/07/2004 | US20040198720 3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 10/07/2004 | US20040198716 Cysteine protease inhimbitors |
| 10/07/2004 | US20040198658 Stanniocalcin polynucleotides, polypeptides and methods based thereon |
| 10/07/2004 | US20040198651 Secreted proteins |
| 10/07/2004 | US20040197876 Recombinant fusion proteins and the trimers thereof |
| 10/07/2004 | US20040197847 High throughput screening assays using fatty acid synthetic enzymes |
| 10/07/2004 | US20040197831 Determining the level in blood or serum and comparing to that of a healthy subject, where a lower concentration indicates the risk Alzheimer's Disease; enzyme-linked immunosorbent assay |
| 10/07/2004 | US20040197469 Apparatus and method for preparing microparticles |
| 10/07/2004 | US20040197429 Selective COX-2 inhibition from plant extracts |
| 10/07/2004 | US20040197405 Multiparticulate modified release composition |
| 10/07/2004 | US20040197404 Extended release oral dosage form |
| 10/07/2004 | US20040197402 Oxcarbazepine dosage forms |
| 10/07/2004 | US20040197399 N-fatty acid-amino acid conjugates and therapeutic uses |
| 10/07/2004 | US20040197345 Prostate derived Ets factor |